The US Senate bill is a vast 2400 pages bill that has been approved by the US recently. The bill is aimed at helping the US compete with China.
The US Senate bill requires the National Institutes of Health (NIH) for new security provisions.
The new security protocols will help the U.S.-funded genomic data from getting misused by China and other countries.
American Society of Human Genetics (ASHG), a few days ago, stated in a letter of lawmaker that there is no provision developed for any substantial risks.
If any substantial risks take place, it may slow biomedical advances and pose unnecessary threats.
Many researchers and experts have welcomed the provisions included in The US Senate bill.
The Innovation and Competition Act (S. 1260) is also applauded by the researchers. The new provisions call to boost federal research spending and new technology interventions at the National Science Foundation.
The new US Senate bill deems the US federal officials to confirm that agencies should appropriately carry on the research approved by NIH, considering the nation’s security risks.
The research and development activities may include human genomic information sequencing, data collection, analysis, or critical and identifiable data storage.
The NIH must issue the comprehensive framework” for managing risks in less than a year. The NIH must take rigorous training of the NIH-funded investigators, reviewers, security leaders.
Responding to the same requirements by the federal government in the past, the NIH had argued that the agency has adequate existing privacy and security measures.